Robust and Expanded Norms for the Dementia Rating Scale
|
|
- Abigayle Foster
- 6 years ago
- Views:
Transcription
1 Archives of Clinical Neuropsychology 25 (2010) Robust and Expanded Norms for the Dementia Rating Scale Otto Pedraza 1, *, John A. Lucas 1, Glenn E. Smith 2, Ronald C. Petersen 3, Neill R. Graff-Radford 4, Robert J. Ivnik 2 1 Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA 2 Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA 3 Department of Neurology, Mayo Clinic, Rochester, MN, USA 4 Department of Neurology, Mayo Clinic, Jacksonville, FL, USA *Corresponding author at: Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL 32224, USA. Tel.: ; fax: address: otto.pedraza@mayo.edu (O. Pedraza). Accepted 26 March 2010 Abstract The Dementia Rating Scale (DRS) is a widely used measure of global cognition, with age- and education-corrected norms derived from a cross-sectional sample of adults participating in Mayo s Older Americans Normative Studies (MOANS). In recent years, however, studies have indicated that cross-sectional normative samples of older adults represent an admixture of individuals who are indeed cognitively normal (i.e., disease-free) and individuals with incipient neurodegenerative disease. Theoretically, the contamination of cross-sectional normative samples with cases of preclinical dementia can lead to underestimation of the test mean and overestimation of the variance, thus reducing the clinical utility of the norms. Robust norming, in which dementia cases are removed from the normative cohort through longitudinal follow-up, is an alternative approach to norm development. The current study presents a reappraisal of the original MOANS DRS norms, provides robust and expanded norms based on a sample of 894 adults age 55 and over, and critically evaluates the benefits of robust norming. Keywords: Dementia Rating Scale; DRS; Alzheimer s disease; Robust; Norms Introduction The Mattis Dementia Rating Scale (DRS) is a widely used measure of global cognition based on performance across five domain subtests (Attention, Initiation/Perseveration, Construction, Conceptualization, and Memory). Lucas and colleagues (1998) provided age- and education-corrected norms derived from a sample of 623 Caucasian adults participating in Mayo s Older Americans Normative Studies (MOANS), and these norms were subsequently adopted into the second edition of the test (Jurica, Leitten, & Mattis, 2001). In the years since the publication of the original MOANS DRS norms, several additional studies have contributed to the DRS normative literature. Lichtenberg and colleagues published age- and education-stratified norms for older Caucasian and African American orthopedic inpatients in an urban medical setting (Bank, Yochim, MacNeill, & Lichtenberg, 2000; Lichtenberg, Ross, Youngblade, & Vangel, 1998), whereas Marcopulos, McLain, and Giuliano (1997; Marcopulos & McLain, 2003) published DRS norms for rural-dwelling Caucasian and African American elders with little to no formal education. In 2005, Rilling and colleagues (2005) published DRS norms derived from 307 participants in Mayo s Older African American Normative Studies (MOAANS). Preliminary norms for Spanish-speaking U.S. residents (Lyness, Hernandez, Chui, & Teng, 2006, 2007) have also recently become available, and DRS performance has been evaluated among American Indians from a Northern Plains tribe in Colorado (Jervis, Beals, Fickensher, & Arciniegas, 2007). More recently, Pedraza and colleagues (2007) provided normative change scores for the DRS in the form of reliable change indices calculated from over 1,000 MOANS and MOAANS participants. # The Author Published by Oxford University Press. All rights reserved. For permissions, please journals.permissions@oxfordjournals.org. doi: /arclin/acq030 Advance Access publication on 28 April 2010
2 348 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Normative reference values for neuropsychological tests usually are obtained from cross-sectional samples of cognitively normal individuals. Cognitive normality is inferred based on clinical history or external criteria such as the absence of impaired scores on other cognitive measures, independence in instrumental activities of daily living, and/or statement of normal cognition obtained from the participant, informant, or primary care physician. Among older adults, however, crosssectional normative samples represent an admixture of individuals who are indeed normal (i.e., disease-free) and individuals with incipient neurodegenerative disease (Saxton et al., 2004; Sliwinski, Lipton, Buschke, & Stewart, 1996). Those at a preclinical stage of neurodegenerative dementia may obtain baseline test scores that are within the realm of expectation when compared with age peers, despite representing a downward cognitive trajectory for the individual. The unintended consequence of including these individuals into conventional normative studies is that it leads to underestimation of the test mean and overestimation of the variance (De Santi et al., 2008; Ritchie, Frerichs, & Tuokko, 2007; Sliwinski et al., 1996). Longitudinal robust norming is a method of establishing normative data that exclude individuals with preclinical dementia. This is accomplished through (a) longitudinal surveillance of all candidates considered at baseline for inclusion into a normative sample, (b) case ascertainment of individuals who change diagnosis away from normal at any time point during follow-up, and (c) exclusion from the normative sample of all cases diagnosed with dementia. Individuals lost to follow-up after their baseline assessment also may be excluded from robust normative samples, particularly if their baseline test scores contribute to a reduction in the test mean and overestimation of the variance (Holtzer et al., 2008). Compared with cross-sectional norms, longitudinal robust norms appear to have greater predictive value in identifying individuals who decline from normal to mild cognitive impairment (MCI) or Alzheimer s disease (AD). De Santi and colleagues (2008) created robust norms for a battery of neuropsychological tests derived from 113 individuals who retained a diagnosis of normal on at least three successive evaluations. These robust norms were then applied to the baseline test scores of an independent cohort of adults followed longitudinally, some of whom eventually declined from normal to MCI or AD. Compared with conventional norms derived from a cross-sectional sample of another 256 participants, robust norms identified a greater proportion of decliners as having cognitive impairment at baseline. Likewise, Holtzer and colleagues (2008) examined data from 1,326 older adults participating in the Einstein Aging Study and created robust norms from a subset of 307 individuals diagnosed as cognitively normal at baseline and during at least two annual follow-up visits. The robust norms identified a larger proportion of baseline cognitive impairment in incident dementia cases than a set of conventional norms. Although better at predicting who will eventually decline from normal cognition to the early stages of AD, the advantage of robust norms appears to diminish once patients advance to a diagnosis of MCI or dementia. Specifically, De Santi and colleagues (2008) found that both conventional and robust norms performed equally well at confirming cognitive impairment among patients with known AD as well as in patients with MCI who progressed to AD. Some studies have failed to identify any advantage to robust norms. Marcopulos and McLain (2003), for example, recalculated norms from a subsample of participants who had contributed to a conventional, cross-sectional normative sample 4 years earlier. Ninety-four of the original 131 participants were retested, and robust norms were derived from a subset of 81 individuals who demonstrated no significant decline when compared with their baseline test performance. The investigators observed that their revised norms did not differ appreciably from the norms calculated from the original conventional sample. They noted, however, that decline was defined psychometrically and no clinical or medical information was obtained to make a formal diagnosis of dementia. As such, it is unclear how many actual incident dementia cases were present in the original sample, the revised sample, or the excluded group of decliners. Ritchie and colleagues (2007) also found no significant difference in the accuracy of conventional versus robust norms derived from the Canadian Study of Health and Aging. This null result was attributed to an equal or lesser-than-expected incidence of dementia in their sample compared with the general population, resulting in minimal contamination in the normative cohort. The authors noted that robust norms may be most useful when the incidence of dementia in the normative sample exceeds that observed in the general population. In aggregate, these studies suggest that longitudinal robust norms are at least equally useful as cross-sectional conventional norms in detecting cognitive impairment among older adults and may be more accurate than conventional norms in predicting preclinical dementia cases. Moreover, robust norms are superior to conventional norms if there is reason to suspect that the incidence of dementia in the normative cohort may be greater than expected in the general population. With the exception of Marcopulos and McLain (2003), to our knowledge the DRS has not been included in any robust normative study. In light of the potential benefits of robust norms, the current study aims to retrospectively review the original MOANS DRS normative cohort, which was derived from a conventional, cross-sectional sample, and determine the proportion of preclinical dementia cases present in that sample. In addition, we update and improve upon the available normative data for the DRS by providing longitudinally robust norms derived from an expanded sample of Caucasian older adults.
3 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Materials and Methods Participants A retrospective review of the Mayo Clinic Alzheimer s Disease Research Center (ADRC) database was conducted to identify community-dwelling, independently functioning adults who met the following criteria at the time of their baseline assessment: (a) age 55 or older, (b) normal cognition based on consensus diagnostic opinion, and (c) administration of the DRS. A consensus diagnosis was rendered at every encounter by a team consisting of at least one behavioral neurologist, clinical neuropsychologist, and nurse or family physician. Normal cognition at baseline was defined based on (a) self, informant and physician reports; (b) capacity to independently perform activities of daily living, based on informant report; (c) no active or uncontrolled central nervous system, systemic, or psychiatric condition that would adversely affect cognition, based on physician report; and (d) no use of psychoactive medications in amounts that would be expected to compromise cognition or for reasons indicating a primary neurologic or psychiatric illness. Importantly, performance on the DRS did not contribute to the baseline diagnosis. Eligible participants with a diagnosis of normal cognition at baseline included 1,175 adults. Of these, 101 individuals were lost to follow-up after their baseline assessment and constitute the single encounter group. Another 180 individuals progressed to a consensus diagnosis other than normal at a follow-up encounter and constitute the preclinical dementia group. Diagnoses at follow-up in this group included MCI (n ¼ 119), AD (n ¼ 39), vascular/mixed dementia (n ¼ 7), dementia with Lewy bodies (n ¼ 3), and other conditions (n ¼ 12). The remaining 894 adults received a consensus diagnosis of normal cognition at every follow-up encounter and constitute the robust normal sample (Fig. 1). APOE genotype, an established risk factor for AD, was available on 99% of all participants (n ¼ 1,165). In addition, all 623 participants in the Lucas and colleagues (1998) normative cohort were specifically reviewed to determine how many remained cognitively normal during subsequent encounters, progressed to dementia, or were lost to follow-up after their baseline testing. Four-hundred and ninety adults (78.5%) out of 623 returned for at least one follow-up visit (range ¼ 1 16). Of these, 334 retained a consensus diagnosis of normal across all visits, 62 progressed to MCI, and 53 progressed to AD. The remaining 41 participants did not retain a primary diagnosis of normal cognition due to other medical conditions (e.g., intracerebral hemorrhage, dementia with Lewy bodies, vascular dementia, Parkinson s disease, posterior cortical atrophy). Overall, 76 (15.5%) out of 490 participants with follow-up encounters (or 12.2% out of all 623 participants) eventually received a primary diagnosis of dementia. Participants from this original cohort who remained cognitively normal during all follow-up visits (n ¼ 334) are included in the current, expanded normative set. That is, the current robust sample of 894 adults includes robust normal individuals (n ¼ 334) from the Lucas and colleagues article, plus a new sample of 560 subjects recruited during the intervening years. All data were obtained in full compliance with study protocols approved by the Mayo Clinic Institutional Review Board. Materials The DRS is a 144-point instrument used in clinical and research settings for the detection, differential diagnosis, and staging of dementia (Jurica et al., 2001). It measures attention, orientation, word fluency, motor initiation and perseveration, visuospatial construction, conceptualization, and memory, which are organized into five domain subtests (Attention, Initiation/ Perseveration, Construction, Conceptualization, and Memory). Test items are arranged hierarchically, and full credit is given to a section if the individual answers the initial items correctly. Administration time usually takes min. Statistical Analyses Group differences for continuous variables were examined using ANOVA with post hoc Tukey s honestly significant difference tests. Group differences for categorical variables were examined with Pearson s chi-squared. Given the unique association Fig. 1. Schematic diagram of study participants.
4 350 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) of education and DRS scores found in the previous Mayo normative study (Lucas et al., 1998) and other samples (Marcopulos et al., 1997; Schmidt et al., 1994; Smith et al., 1994), hierarchical linear regression was used to explore this relationship in the robust normal group. Age was entered first into the hierarchical model, followed by education. The methodology used to develop the current norms was similar to that used in previous Mayo normative studies (e.g., Ivnik et al., 1990; Lucas et al., 2005). Specifically, an a priori decision was made to include a minimum of 70 individuals within each age group to increase the likelihood of stable estimates. Individuals at the extreme ends of the age distribution were combined until the minimum sample size of 70 was reached. Overlapping midpoint age intervals were used to maximize the available information, with midpoints selected at 3-year intervals and a range around each midpoint of +5 years (Pauker, 1988). The distribution of raw scores within each midpoint age group was then normalized by assigning standard scores based on actual percentile ranks. This strategy provides a normative reference for adults surrounding a particular age point. For additional details regarding this methodology, see Ivnik and colleagues (1990). Results Demographic characteristics and mean DRS total scores for all 1,175 participants in the updated sample are presented in Table 1. The three groups differed on age, F(2, 1172) ¼ 9.46, p,.001, and education, F(2, 1172) ¼ 4.83, p,.01. Specifically, robust normal participants were marginally younger than single encounter (p ¼.05) and significantly younger than preclinical dementia (p,.001) participants. Robust normal participants had a significantly higher level of education than single encounter participants (p,.05), but not when compared with preclinical dementia participants. There was no significant difference between the groups on sex distribution, x 2 (2) ¼.57, p ¼.75. Robust normals had the lowest proportion of APOE 14 allele carriers (23.6%); however, this was not significantly different when compared with the proportion of APOE 14 carriers among single encounter, x 2 (1) ¼ 1.85, p ¼.17, or preclinical dementia, x 2 (1) ¼ 3.63, p ¼.06 groups. When considering only the robust normal sample, 11 adults (1.2%) were APOE 14/4 homozygotes. As expected, mean total DRS scores differed among the three groups, F(2, 1172) ¼ 16.30, p,.001, with robust normals obtaining a significantly higher mean DRS score compared with single encounter (p,.001) and preclinical dementia (p,.001) participants. Consistent with prior studies on the effects of robust norming, the conventional (full) sample of 1,175 participants (M ¼ 135.8, SD ¼ 5.8) underestimated the DRS mean and overestimated the variance when compared with the robust subsample. Moreover, this effect was also evident when comparing the current robust subsample with the mean DRS score (M ¼ 134.7, SD ¼ 6.8) calculated from the original subsample of 623 participants. Frequency distributions of demographic data and study encounters for the robust normative sample are presented in Table 2. Approximately 89% of the sample had at least two follow-up visits and almost half (45.3%) had a minimum of five follow-up visits during which a consensus diagnosis of normal was retained. Among preclinical dementia cases, the median number of follow-up visits was four and the mode was six (range ¼ 1 8). Single encounter participants were lost to follow-up for a variety reasons, but no formal attempt has been made to ascertain the specific factors contributing to their study withdrawal. Table 3 shows the association between demographic variables and DRS scores in robust normal participants. As expected, age and education were significantly associated with the majority of DRS subtest and total scores. Sex was associated only with the Construction subtest, accounting for less than 1% of variance (r 2 ¼.008). To determine if this association was sufficiently relevant to stratify the Construction subtest in our normative tables, we then analyzed the mean Construction scores between men and women across 5-year age bands. Mean Construction scores were significantly different for men and women only between the ages of 80 and 84, with women obtaining on average 0.12 points more than men. Across all ages, the mean Construction subtest score for men was 5.73 and women Given the rather trivial relationship between sex and Construction subtest scores in our sample, and the lack of association to any other DRS subtest, it was not considered for the normative analyses. Table 1. Characteristics of robust normal (n ¼ 894), single encounter (n ¼ 101), and preclinical dementia (n ¼ 180) participants Robust normals Single encounter Preclinical dementia M SD M SD M SD Age Education DRS total Men (%) APOE 14 (%) Note: DRS ¼ Dementia Rating Scale.
5 Table 2. Frequency distribution of robust normative sample (n ¼ 894) O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) n Relative frequency (%) Cumulative frequency (%) Age (years) Education (years), Gender Men Women Follow-up encounters a a Number of follow-up encounters in which a consensus diagnosis of normal cognition was rendered. Table 3. Correlation coefficients and shared variances of DRS subtest and total scores with demographic variables (n ¼ 894) Age Sex a Education r r 2 r r 2 r r 2 Attention 2.15** **.03 Initiation/Perseveration 2.22** **.03 Construction **.01.08*.01 Conceptualization 2.27** **.08 Memory 2.24** **.02 Total score 2.34** **.09 Note: DRS ¼ Dementia Rating Scale. a Point-biserial correlations. *p,.05. **p,.01. Normative data for DRS subtest and total scores are presented in Tables Robust age-corrected scaled scores are presented in the leftmost column of each table, with corresponding percentile ranks in the rightmost column. To use these norms, first select the table corresponding to the patient s age at the time of test administration. Then search for the patient s raw score and refer across to the corresponding scaled score (M ¼ 10, SD ¼ 3) and percentile rank. The age range and sample size used to create norms for each group are provided beneath each table.
6 352 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Table 4. Robust norms for persons under age 67 2,31,28,3,29,19,123, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 55 70, n ¼ 115. Table 5. Robust norms for persons of age years 2,31,27,3,29,19,123, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 63 73, n ¼ 262. Results from the hierarchical linear regression model showed education to contribute unique variance to DRS total scores, F(2, 891) ¼ 108.9, p,.001, with an increment from r 2 ¼.12 in the age-only model to r 2 ¼.20 in the age and education model. To aid clinicians and investigators using the DRS, robust age- and education-corrected scaled scores can be derived for the total raw score using the equation presented in Table 14. Scaling constraints due to marked deviation from normality precluded education adjustments for each DRS subtest. Finally, a preliminary post hoc analysis was performed of the incremental diagnostic validity and clinical utility of these robust norms in the detection of baseline cognitive impairment in preclinical dementia cases. Scaled scores were obtained for baseline DRS total scores from 49 preclinical dementia cases (39 AD, 10 with other dementia diagnoses) using robust and original norms. These scores were compared with the baseline scaled scores from 49 cognitively normal adults selected from the robust sample. To minimize the likelihood of spurious findings, 3 separate random samples (with replacement) of 49 cognitively normal adults were drawn. Cognitive impairment was defined as a scaled score lower than 7. Across the three
7 Table 6. Robust norms for persons of age years O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) ,30,27,3,28,19,121, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 66 76, n ¼ 358. Table 7. Robust norms for persons of age years 2,29,27,3,28,19,121, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 69 79, n ¼ 460. comparisons, use of the original norms resulted in sensitivity of 14.3%, whereas the new robust norms resulted in sensitivity of 24.5%. Specificity using original norms ranged from 91.8% to 95.9%, and using robust norms ranged from 89.8% to 93.9%. Positive predictive values ranged from 63.6% to 77.8% using the original norms and 70.6% to 80.0% using robust norms, an average increase of 3.2%. Negative predictive values ranged from 51.7% to 52.8% using original norms and 54.3% to 55.4% using robust norms, an average increase of 2.4%. Discussion The purpose of this study was twofold: First, to retrospectively review the original MOANS DRS normative sample and determine how many cases of preclinical dementia were present; and second, to update the available DRS norms with an expanded, longitudinally robust sample. Of the 490 adults in the original sample who returned for additional evaluations,
8 354 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Table 8. Robust norms for persons of age years 2,28,27,3,28,19,120, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 72 82, n ¼ 488. Table 9. Robust norms for persons of age years 2,28,27,3,28,16,116, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; Range ¼ 75 85, n ¼ of them obtained a follow-up diagnosis of MCI and another 53 eventually progressed to AD. Considering the 1,074 adults in the expanded sample who had normal cognition at baseline and at least one follow-up visit, approximately 6% constituted cases of preclinical dementia. This rate is generally consistent with other robust normative studies in suggesting that cross-sectional norms may contain a non-trivial number of individuals at a preclinical stage of neurodegenerative dementia. For instance, Holtzer and colleagues (2008) reported a 4.6% rate of preclinical dementia cases, Saxton and colleagues (2004) reported a 10.4% rate of preclinical AD cases, and De Santi and colleagues (2008) reported a 16.1% rate of preclinical AD cases. Moreover, it is now clear that our original norms slightly underestimated the overall DRS mean and overestimated the variance when compared with a robust sample of cognitively normal adults. There are several strengths to the present investigation. First, by revisiting the original normative sample and conducting a critical reappraisal, we have confidence that the robust norms provided in this article represent an accurate depiction of DRS performance among cognitively normal (i.e., disease-free) older adults. Second, by excluding from the robust sample not only
9 Table 10. Robust norms for persons of age years O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) ,28,26,3,24,15,114, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; range ¼ 78 88, n ¼ 418. Table 11. Robust norms for persons of age years 2,28,24,3,24,15,113, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; range ¼ 81 91, n ¼ 309. individuals who have progressed to dementia but also those with MCI or a single encounter, we have minimized the likelihood that those with any incipient neurodegenerative process would be included. We are aware that not all individuals with MCI will progress inexorably toward dementia and many will revert back to normal. However, our conservative approach ensures that this normative cohort is as free of neurodegenerative disease as theoretically possible. Third, we considered the role of APOE in the selection of the normative sample. The proportion of APOE 14 carriers was not significantly different between the robust and preclinical dementia samples, although there was a trend toward more 14 carriers in the preclinical dementia group. Only 11 participants in the robust sample were 14 homozygotes, and their mean DRS score of (SD ¼ 5.6) was similar to the mean DRS score for the entire robust sample. For this reason, we opted to keep these 11 individuals in the normative group. Fourth, the current study draws from a relatively large sample size and includes a substantial number of adults 80 years of age and older.
10 356 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Table 12. Robust norms for persons of age years 2,28,21,2,22,13,111, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; range ¼ 84 94, n ¼ 175. Table 13. Robust norms for persons of age over 90 years 2,28,21,2,20,7,102, Notes: Init./Pers. ¼ Initiation/Perseveration; Const. ¼ Construction; Concept. ¼ Conceptualization; range ¼ , n ¼ 92. Table 14. Steps to obtain robust age- and education-corrected scaled scores for total DRS raw scores Obtain the robust age-corrected scaled score (racss) from the appropriate table (Tables 4 13) Determine the years of formal education completed (EDUC) Calculate the robust age- and education-corrected scaled score (raecss) using the following formula: raecss ¼ (1.16 racss) (0.32 EDUC) Note: DRS ¼ Dementia Rating Scale. Finally, a preliminary validation of the diagnostic and clinical utility of these updated, robust norms was performed. When considering the DRS scores of preclinical dementia cases at baseline, the robust norms result in an almost twofold increase in sensitivity with relatively minimal loss of specificity when compared with the original norms. Moreover, in this preliminary analysis, the use of the updated robust norms contributes to net gains in positive (3.2%) and negative predictive values (2.4%).
11 Although these gains are relatively modest, the reader is urged to remember that these are comparisons of baseline, preclinical DRS scores (i.e., prior to a clinical diagnosis of dementia). The modest magnitude of these gains suggests that in wellcharacterized, large normative cohorts in which the incidence of dementia does not exceed substantially that found in the general population, there is likely to be minimal contamination of test scores. As such, the extraordinary efforts and funding required to follow large cohorts longitudinally may not be practical for the sole purpose of deriving robust norms. Rather, the development of such norms may be most feasible in centers where longitudinal neuropsychological data are collected in service of other primary aims. As noted in the original DRS normative study, the validity of all norms depends on the extent to which the test-taker shares similarities with the normative sample. The robust MOANS sample in the current study is comprised of Caucasian adults predominantly living in economically stable areas in the Midwest region of the USA. The underrepresentation of participants with limited education warrants caution when applying these norms to those with fewer than 8 years of formal education. DRS normative data for African American older adults are also available (Rilling et al., 2005). Over the past two decades, investigators at the Mayo Clinic have provided normative data for a variety of neuropsychological tests under the auspices of the MOANS and MOAANS projects. It is hoped that the robust norms for the DRS presented in this article will be beneficial to clinicians and investigators in their evaluation of older adults. Funding This work was supported by the National Institutes of Health (NS to OP, AG00831 to JAL, GES, NRG, RCP, RJI, AG to JAL, GES, NRG, RCP, RJI, AG to RCP, RJI); and the State of Florida Alzheimer s Disease Initiative (FL-2J-02 to JAL, NRG). Conflict of Interest None declared. Acknowledgements We are grateful for the assistance of staff members in the Psychological Assessment Laboratory at Mayo Clinic Alzheimer s Disease Research Center (ADRC) and the Memory Disorders Clinic at Mayo Clinic, Florida. We also want to thank Roger A. Mueller and Matthew R. Miller for their invaluable database assistance. References O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Bank, A. L., Yochim, B. P., MacNeill, S. E., & Lichtenberg, P. A. (2000). Expanded normative data for the Mattis Dementia Rating Scale for use with urban, elderly medical patients. The Clinical Neuropsychologist, 14 (2), De Santi, S., Pirraglia, E., Barr, W., Babb, J., Williams, S., Rogers, K., et al. (2008). Robust and conventional neuropsychological norms: Diagnosis and prediction of age-related cognitive decline. Neuropsychology, 22 (4), Holtzer, R., Goldin, Y., Zimmerman, M., Katz, M., Buschke, H., & Lipton, R. B. (2008). Robust norms for selected neuropsychological tests in older adults. Archives of Clinical Neuropsychology, 23, Ivnik, R. J., Malec, J. F., Tangalos, E. G., Petersen, R. C., Kokmen, E., & Kurland, L. T. (1990). The Auditory Verbal Learning Test (AVLT): Norms of ages 55 and older. Psychological Assessment, 2, Jervis, L. J., Beals, J., Fickensher, A., & Arciniegas, D. B. (2007). Performance on the Mini-Mental State Examination and Mattis Dementia Rating Scale among older American Indians. The Journal of Neuropsychiatry and Clinical Neurosciences, 19, Jurica, P. J., Leitten, C. L., & Mattis, S. (2001). Dementia Rating Scale-2: Professional manual. Lutz: Psychological Assessment Resources. Lichtenberg, P. A., Ross, T., Youngblade, L., & Vangel, S. J. (1998). Normative Studies Research Project test battery: Detection of dementia in African American and European American urban elderly patients. The Clinical Neuropsychologist, 12, Lucas, J. A., Ivnik, R. J., Smith, G. E., Bohac, D. L., Tangalos, E. G., Graff-Radford, N. R., et al. (1998). Normative data for the Mattis Dementia Rating Scale. Journal of Clinical and Experimental Neuropsychology, 20, Lucas, J. A., Ivnik, R. J., Willis, F. B., Ferman, T. J., Smith, G. E., Parfitt, F. C., et al. (2005). Mayo s Older African Americans Normative Studies: Normative data for commonly used clinical neuropsychological measures. The Clinical Neuropsychologist, 19, Lyness, S. A., Hernandez, I., Chui, H. C., & Teng, E. L. (2006). Performance of Spanish speakers on the Mattis Dementia Rating Scale (MDRS). Archives of Clinical Neuropsychology, 21, Lyness, S. A., Hernandez, I., Chui, H. C., & Teng, E. L. (2007). Erratum to Performance of Spanish speakers on the Mattis Dementia Rating Scale (MDRS). Archives of Clinical Neuropsychology, 22, 131. Marcopulos, B. A., & McLain, C. A. (2003). Are our norms normal? A 4-year follow-up study of a biracial sample of rural elders with low education. The Clinical Neuropsychologist, 17 (1),
12 358 O. Pedraza et al. / Archives of Clinical Neuropsychology 25 (2010) Marcopulos, B. A., McLain, C. A., & Giuliano, A. J. (1997). Cognitive impairment or inadequate norms? A study of healthy, rural, older adults with limited education. The Clinical Neuropsychologist, 11, Pauker, J. D. (1988). Constructing overlapping cell tables to maximize the clinical usefulness of normative test data: Rationale and an example from neuropsychology. Journal of Clinical Psychology, 44, Pedraza, O., Smith, G. E., Ivnik, R. J., Willis, F. B., Ferman, T. J., Petersen, R. C., et al. (2007). Reliable change on the Dementia Rating Scale. Journal of the International Neuropsychological Society, 13 (4), Rilling, L. M., Lucas, J. A., Ivnik, R. J., Smith, G. E., Willis, F. B., Ferman, T. J., et al. (2005). Mayo s Older African American Normative Studies: Norms for the Mattis Dementia Rating Scale. The Clinical Neuropsychologist, 19 (2), Ritchie, L. J., Frerichs, R. J., & Tuokko, H. (2007). Effective normative samples for the detection of cognitive impairment in older adults. The Clinical Neuropsychologist, 21, Saxton, J., Lopez, O. L., Ratcliff, G., Dulberg, C., Fried, L. P., Carlson, M. C., et al. (2004). Preclinical Alzheimer s disease: Neuropsychological test performance 1.5 to 8 years prior to onset. Neurology, 63, Schmidt, R., Freidl, W., Fazekas, F., Reinhart, B., Grieshofer, P., Koch, M., et al. (1994). The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers. Neurology, 44 (5), Sliwinski, M., Lipton, R. B., Buschke, H., & Stewart, W. (1996). The effects of preclinical dementia on estimates of normal cognitive functioning in aging. Journal of Gerontology, Series B: Psychological Sciences and Social Sciences, 51 (4), Smith, G. E., Ivnik, R. J., Malec, J. F., Kokmen, E., Tangalos, E., & Petersen, R. C. (1994). Psychometric properties of the Mattis Dementia Rating Scale. Assessment, 1 (2),
ORIGINAL CONTRIBUTION. Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals
ORIGINAL CONTRIBUTION Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals Sid E. O Bryant, PhD; Joy D. Humphreys, MA; Glenn E. Smith, PhD; Robert J. Ivnik, PhD; Neill
More informationElderly Norms for the Hopkins Verbal Learning Test-Revised*
The Clinical Neuropsychologist -//-$., Vol., No., pp. - Swets & Zeitlinger Elderly Norms for the Hopkins Verbal Learning Test-Revised* Rodney D. Vanderploeg, John A. Schinka, Tatyana Jones, Brent J. Small,
More informationA semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans
Archives of Clinical Neuropsychology 20 (2005) 199 208 A semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans Hector M. González a,, Dan Mungas b, Mary N. Haan a a University
More informationORIGINAL CONTRIBUTION. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment
ORIGINAL CONTRIBUTION Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment David F. Tang-Wai, MDCM; David S. Knopman, MD; Yonas E. Geda, MD;
More informationCHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
More informationRapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition
Archives of Clinical Neuropsychology 22 (2007) 917 924 Abstract Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition Alison J. Donnell a, Neil Pliskin a, James Holdnack
More informationORIGINAL CONTRIBUTION. Five-Year Follow-up of Cognitive Impairment
ORIGINAL CONTRIBUTION Five-Year Follow-up of Cognitive Impairment With No Dementia Holly Tuokko, PhD; Robert Frerichs, MSc; Janice Graham, PhD; Kenneth Rockwood, MD; Betsy Kristjansson, PhD; John Fisk,
More informationClinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly
Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance
More informationNaming Test of the Neuropsychological Assessment Battery: Convergent and Discriminant Validity
Archives of Clinical Neuropsychology 24 (2009) 575 583 Naming Test of the Neuropsychological Assessment Battery: Convergent and Discriminant Validity Brian P. Yochim*, Katherine D. Kane, Anne E. Mueller
More informationEveryday Problem Solving and Instrumental Activities of Daily Living: Support for Domain Specificity
Behav. Sci. 2013, 3, 170 191; doi:10.3390/bs3010170 Article OPEN ACCESS behavioral sciences ISSN 2076-328X www.mdpi.com/journal/behavsci Everyday Problem Solving and Instrumental Activities of Daily Living:
More informationTrail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6
NEUROLOGY/2016/790584 Table e-1: Neuropsychological test battery Cognitive domain Test Attention/processing speed Digit symbol-coding 1 Trail making test A 2,3 Memory Logical memory Story A delayed recall
More informationPRINCIPLES OF STATISTICS
PRINCIPLES OF STATISTICS STA-201-TE This TECEP is an introduction to descriptive and inferential statistics. Topics include: measures of central tendency, variability, correlation, regression, hypothesis
More informationComparison of Predicted-difference, Simple-difference, and Premorbid-estimation methodologies for evaluating IQ and memory score discrepancies
Archives of Clinical Neuropsychology 19 (2004) 363 374 Comparison of Predicted-difference, Simple-difference, and Premorbid-estimation methodologies for evaluating IQ and memory score discrepancies Reid
More informationI n recent years, the concept of mild cognitive impairment
1275 PAPER Mild cognitive impairment: a cross-national comparison E Arnáiz, O Almkvist, R J Ivnik, E G Tangalos, L O Wahlund, B Winblad, R C Petersen... See end of article for authors affiliations... Correspondence
More informationInterpreting change on the WAIS-III/WMS-III in clinical samples
Archives of Clinical Neuropsychology 16 (2001) 183±191 Interpreting change on the WAIS-III/WMS-III in clinical samples Grant L. Iverson* Department of Psychiatry, University of British Columbia, 2255 Wesbrook
More informationMinimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment
Original Research Article DOI: 10.1159/000215390 Accepted: January 30, 2009 Published online: April 28, 2009 Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment Brian
More informationThe Short NART: Cross-validation, relationship to IQ and some practical considerations
British journal of Clinical Psychology (1991), 30, 223-229 Printed in Great Britain 2 2 3 1991 The British Psychological Society The Short NART: Cross-validation, relationship to IQ and some practical
More informationTHE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME
PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence
More informationHealthy Children Get Low Scores Too: Prevalence of Low Scores on the NEPSY-II in Preschoolers, Children, and Adolescents
Archives of Clinical Neuropsychology 25 (2010) 182 190 Healthy Children Get Low Scores Too: Prevalence of Low Scores on the NEPSY-II in Preschoolers, Children, and Adolescents Brian L. Brooks 1, *, Elisabeth
More informationCHAPTER 4 RESULTS. In this chapter the results of the empirical research are reported and discussed in the following order:
71 CHAPTER 4 RESULTS 4.1 INTRODUCTION In this chapter the results of the empirical research are reported and discussed in the following order: (1) Descriptive statistics of the sample; the extraneous variables;
More informationAdverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease
Adverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease J. Sukanya 05.Jul.2012 Outline Background Methods Results Discussion Appraisal Background Common outcomes in hospitalized
More informationMMPI-2 short form proposal: CAUTION
Archives of Clinical Neuropsychology 18 (2003) 521 527 Abstract MMPI-2 short form proposal: CAUTION Carlton S. Gass, Camille Gonzalez Neuropsychology Division, Psychology Service (116-B), Veterans Affairs
More informationChapter 3. Psychometric Properties
Chapter 3 Psychometric Properties Reliability The reliability of an assessment tool like the DECA-C is defined as, the consistency of scores obtained by the same person when reexamined with the same test
More informationImproving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan
Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Grant L. Iverson, Ph.D, Professor Department of Physical Medicine and Rehabilitation Harvard Medical School & Red Sox
More informationPTHP 7101 Research 1 Chapter Assignments
PTHP 7101 Research 1 Chapter Assignments INSTRUCTIONS: Go over the questions/pointers pertaining to the chapters and turn in a hard copy of your answers at the beginning of class (on the day that it is
More informationBaseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston
Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationThe significance of sensory motor functions as indicators of brain dysfunction in children
Archives of Clinical Neuropsychology 18 (2003) 11 18 The significance of sensory motor functions as indicators of brain dysfunction in children Abstract Ralph M. Reitan, Deborah Wolfson Reitan Neuropsychology
More information21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist
Today s webinar will answer. 1. What is the RBANS, and how is the updated version different than the original version? 2. What are the neurocognitive areas assessed by the RBANS and what scores are available?
More informationData and Statistics 101: Key Concepts in the Collection, Analysis, and Application of Child Welfare Data
TECHNICAL REPORT Data and Statistics 101: Key Concepts in the Collection, Analysis, and Application of Child Welfare Data CONTENTS Executive Summary...1 Introduction...2 Overview of Data Analysis Concepts...2
More informationS ubjects with mild cognitive impairment (MCI) often
1348 PAPER Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer s disease? P J Visser, P Scheltens, F R J Verhey... See end of article for authors affiliations... Correspondence
More informationFamily Planning Programs and Fertility Preferences in Northern Ghana. Abstract
Family Planning Programs and Fertility Preferences in Northern Ghana Abstract This paper contributes to understanding the associations between a culturally sensitive family planning program and fertility
More informationalternate-form reliability The degree to which two or more versions of the same test correlate with one another. In clinical studies in which a given function is going to be tested more than once over
More informationTasks of Executive Control TEC. Score Report. Developed by Peter K. Isquith, PhD, Robert M. Roth, PhD, Gerard A. Gioia, PhD, and PAR Staff
Tasks of Executive Control TEC Score Report Developed by Peter K. Isquith, PhD, Robert M. Roth, PhD, Gerard A. Gioia, PhD, and PAR Staff Client Information Client Name: Sample Client Client ID: Website
More informationRecognizing Dementia can be Tricky
Dementia Abstract Recognizing Dementia can be Tricky Dementia is characterized by multiple cognitive impairments that cause significant functional decline. Based on this brief definition, the initial expectation
More informationSTATISTICS AND RESEARCH DESIGN
Statistics 1 STATISTICS AND RESEARCH DESIGN These are subjects that are frequently confused. Both subjects often evoke student anxiety and avoidance. To further complicate matters, both areas appear have
More informationStatistical analysis DIANA SAPLACAN 2017 * SLIDES ADAPTED BASED ON LECTURE NOTES BY ALMA LEORA CULEN
Statistical analysis DIANA SAPLACAN 2017 * SLIDES ADAPTED BASED ON LECTURE NOTES BY ALMA LEORA CULEN Vs. 2 Background 3 There are different types of research methods to study behaviour: Descriptive: observations,
More informationThe Impact of Relative Standards on the Propensity to Disclose. Alessandro Acquisti, Leslie K. John, George Loewenstein WEB APPENDIX
The Impact of Relative Standards on the Propensity to Disclose Alessandro Acquisti, Leslie K. John, George Loewenstein WEB APPENDIX 2 Web Appendix A: Panel data estimation approach As noted in the main
More informationValidity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease
Genetic Epidemiology 15:215 223 (1998) Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease G. Devi, 1,3 * K. Marder, 1,3 P.W. Schofield,
More informationMICHAEL PRITCHARD. most of the high figures for psychiatric morbidity. assuming that a diagnosis of psychiatric disorder has
Postgraduate Medical Journal (November 1972) 48, 645-651. Who sees a psychiatrist? A study of factors related to psychiatric referral in the general hospital Summary A retrospective study was made of all
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More informationIntra-Individual Reaction Time Variability in Mild Cognitive Impairment and Alzheimer s Disease: Gender, Processing Load and Speed Factors
Intra-Individual Reaction Time Variability in Mild Cognitive Impairment and Alzheimer s Disease: Gender, Processing Load and Speed Factors Michelle Phillips 1, Peter Rogers 2, Judy Haworth 3, Antony Bayer
More informationOLDER ADULTS LEARNING, MEMORY, AND COPY PERFORMANCE ON THE REY-OSTERRIETH AND MODIFIED TAYLOR COMPLEX FIGURES
The University of British Columbia OLDER ADULTS LEARNING, MEMORY, AND COPY PERFORMANCE ON THE REY-OSTERRIETH AND MODIFIED TAYLOR COMPLEX FIGURES Anita M. Hubley University of British Columbia Vancouver,
More informationAD Prevention Trials: An Industry Perspective
AD Prevention Trials: An Industry Perspective Robert A. Lasser, MD, MBA Global Development Lead, Product Development Group Medical Director, Neurodegenerative Disorders F. Hoffmann - La Roche Ltd Regulatory
More informationA normative study of the CERAD neuropsychological assessment battery in the Korean elderly
Journal of the International Neuropsychological Society (2004), 10, 72 81. Copyright 2004 INS. Published by Cambridge University Press. Printed in the USA. DOI: 10.10170S1355617704101094 A normative study
More informationProceedings of the Annual Meeting of the American Statistical Association, August 5-9, 2001
Proceedings of the Annual Meeting of the American Statistical Association, August 5-9, 1 SCREENING FOR DEMENTIA USING LONGITUDINAL MEASUREMENTS OF COGNITION Christopher H. Morrell, Mathematical Sciences
More informationTrajectories of different cognitive domains in community-dwelling older adults
Trajectories of different cognitive domains in community-dwelling older adults Jennifer Tang, Tianyin Liu, Gloria Wong, Mandy Lau, & Terry Lum 32 nd International Conference of Alzheimer s Disease International
More informationORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS
ORIGINAL ARTICLE Neuroscience DOI: 10.46/jkms.2010.25.7.1071 J Korean Med Sci 2010; 25: 1071-1076 Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring
More informationConcurrent validity of WAIS-III short forms in a geriatric sample with suspected dementia: Verbal, performance and full scale IQ scores
Archives of Clinical Neuropsychology 20 (2005) 1043 1051 Concurrent validity of WAIS-III short forms in a geriatric sample with suspected dementia: Verbal, performance and full scale IQ scores Brian L.
More informationThe Zarit Burden Interview: A New Short Version and Screening Version
The Gerontologist Vol. 41, No. 5, 652 657 Copyright 2001 by The Gerontological Society of America The Zarit Burden Interview: A New Short Version and Screening Version Michel Bédard, PhD, 1,2 D. William
More informationDescribe what is meant by a placebo Contrast the double-blind procedure with the single-blind procedure Review the structure for organizing a memo
Business Statistics The following was provided by Dr. Suzanne Delaney, and is a comprehensive review of Business Statistics. The workshop instructor will provide relevant examples during the Skills Assessment
More informationHopkins Verbal Learning Test Revised: Norms for Elderly African Americans
The Clinical Neuropsychologist 1385-4046/02/1603-356$16.00 2002, Vol. 16, No. 3, pp. 356 372 # Swets & Zeitlinger Hopkins Verbal Learning Test Revised: Norms for Elderly African Americans Melissa A. Friedman
More informationWHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide December 2012
WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide December 2012 1. Introduction Changes in the current update (December 2012): New data sets Post Trial - Form A, Phase 2: Administration
More informationEstimates of the Reliability and Criterion Validity of the Adolescent SASSI-A2
Estimates of the Reliability and Criterion Validity of the Adolescent SASSI-A 01 Camelot Lane Springville, IN 4746 800-76-056 www.sassi.com In 013, the SASSI Profile Sheets were updated to reflect changes
More informationTest-retest reliable coefficients and 5-year change scores for the MMSE and 3MS
Archives of Clinical Neuropsychology 20 (2005) 485 503 Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS Tom N. Tombaugh Psychology Department, Carleton University, 1125 Colonel
More informationTest review. Comprehensive Trail Making Test (CTMT) By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., Test description
Archives of Clinical Neuropsychology 19 (2004) 703 708 Test review Comprehensive Trail Making Test (CTMT) By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., 2002 1. Test description The Trail Making Test
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationKailey Leroux M.Cl.Sc SLP Candidate Western University: School of Communication Sciences and Disorders
Critical Review: In children with cochlear implants, is an oral communication approach more effective than a total communication approach at improving speech and language skills? Kailey Leroux M.Cl.Sc
More informationBRIEF cognitive rating scales are commonly used in the
Journal of Gerontology: PSYCHOLOGICAL SCIENCES 1998, Vol. 53B, No. 6, P37O-P374 Copyright 1998 by The Gerontological Society of America An Analysis of Test Bias and Differential Item Functioning Due to
More informationPartners in Care: A Model of Social Work in Primary Care
Partners in Care: A Model of Social Work in Primary Care Common problems in the elderly, such as reduced cognitive functioning, depression, medication safety, sleep abnormalities, and falls have been shown
More informationTreatment of AD with Stabilized Oral NADH: Preliminary Findings
MS # 200 000 128 Treatment of AD with Stabilized Oral NADH: Preliminary Findings G.G. Kay, PhD, V. N. Starbuck, PhD and S. L. Cohan, MD, PhD Department of Neurology, Georgetown University School of Medicine
More informationTest Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition
Table S. Cognitive tests used in the Georgia Centenarian Study. Test Assessment Description Ref. Mini-Mental State Examination Global cognitive performance A brief screening of orientation, memory, executive
More informationChapter 31 Psychometric Foundations for the Interpretation of Neuropsychological Test Results *
Chapter 31 Psychometric Foundations for the Interpretation of Neuropsychological Test Results * Brian L. Brooks, Elisabeth M.S. Sherman, Grant L. Iverson, Daniel J. Slick, and Esther Strauss Abstract The
More informationCognitive Reserve and the Relationship Between Depressive Symptoms and Awareness of Deficits in Dementia
Cognitive Reserve and the Relationship Between Depressive Symptoms and Awareness of Deficits in Dementia Mary Beth Spitznagel, Ph.D. Geoffrey Tremont, Ph.D. Laura B. Brown, Ph.D. John Gunstad, Ph.D. Depression
More informationexamination in the initial assessment of overdose patients
Archives of Emergency Medicine, 1988, 5, 139-145 Use of abbreviated mental status examination in the initial assessment of overdose patients K. S. MERIGIAN,1 J. R. HEDGES,1 J. R. ROBERTS,1 R. A. CHILDRESS,'
More informationA Coding System to Measure Elements of Shared Decision Making During Psychiatric Visits
Measuring Shared Decision Making -- 1 A Coding System to Measure Elements of Shared Decision Making During Psychiatric Visits Michelle P. Salyers, Ph.D. 1481 W. 10 th Street Indianapolis, IN 46202 mpsalyer@iupui.edu
More informationChapter V Depression and Women with Spinal Cord Injury
1 Chapter V Depression and Women with Spinal Cord Injury L ike all women with disabilities, women with spinal cord injury (SCI) may be at an elevated risk for depression due to the double jeopardy of being
More informationLambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School
Lambros Messinis PhD Neuropsychology Section, Department of Neurology, University of Patras Medical School Type 2 Diabetes Mellitus is a modern day epidemic Age is a significant predictor of diabetes Males
More informationPlenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo
Plenary Session 2 Psychometric Assessment Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo Reliability Validity Group Discrimination, Sensitivity Validity Association
More informationDemystifying the Neuropsychological Evaluation Report. Clinical Neuropsychologist 17 March 2017 Program Director, Neurobehavioral Program
Demystifying the Neuropsychological Evaluation Report Jennifer R. Cromer, PhD BIAC Annual Conference Clinical Neuropsychologist 17 March 2017 Program Director, Neurobehavioral Program 84% of neuropsychologists
More informationTasks of Executive Control TEC. Protocol Summary Report. Developed by Peter K. Isquith, PhD, Robert M. Roth, PhD, Gerard A. Gioia, PhD, and PAR Staff
Tasks of Executive Control TEC Protocol Summary Report Developed by Peter K. Isquith, PhD, Robert M. Roth, PhD, Gerard A. Gioia, PhD, and PAR Staff Report Information Name: Sample Client Gender: Male Date
More informationNEUROPSYCHOLOGICAL ASSESSMENT
English 3 CANADIAN STUDY OF HEALTH AND AGING - 3 NEUROPSYCHOLOGICAL ASSESSMENT Interview date: / / DD MM YYYY Time started : (24 Hour clock) Page 2 completed by coordinator Pages 3 to 16 completed by psychometrist
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationGeriatric performance on the Neurobehavioral Cognitive Status Examination (Cognistat) What is normal?
Archives of Clinical Neuropsychology 18 (2003) 463 471 Geriatric performance on the Neurobehavioral Cognitive Status Examination (Cognistat) What is normal? Abstract Caitlin Macaulay a,, Matthew Battista
More informationPiano playing skills in a patient with frontotemporal dementia: A longitudinal case study
International Symposium on Performance Science ISBN 978-94-90306-01-4 The Author 2009, Published by the AEC All rights reserved Piano playing skills in a patient with frontotemporal dementia: A longitudinal
More informationWHOS complex needs clients data survey: assessment and treatment options
2 WHOS complex needs clients data survey: assessment and treatment options Assessment options: peer-reviewed and grey literature; policy, procedure and practice (PPP) 1: People With Exceptionally Complex
More informationBusiness Statistics Probability
Business Statistics The following was provided by Dr. Suzanne Delaney, and is a comprehensive review of Business Statistics. The workshop instructor will provide relevant examples during the Skills Assessment
More informationOn the purpose of testing:
Why Evaluation & Assessment is Important Feedback to students Feedback to teachers Information to parents Information for selection and certification Information for accountability Incentives to increase
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationTOPF (Test of Pre-Morbid Function)
TEST OF PREMORBID FUNCTIONING TOPF (Test of Pre-Morbid Function) Case Studies TOPF (Test of Pre-Morbid Function) Case Studies Case Study 1 Client C is a 62-year-old White male with 18 years of education,
More informationNO LOWER COGNITIVE FUNCTIONING IN OLDER ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
CHAPTER 6 NO LOWER COGNITIVE FUNCTIONING IN OLDER ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER INT PSYCHOGERIATR, 2015, 27(9): 1467 1476 DOI: 10.1017/S1041610215000010 73 NO LOWER COGNITIVE FUNCTIONING
More informationRunning head: BEHAVIORAL ASSESSMENT TOOLS TO IDENTIFY PAIN. Effectiveness of a Behavior Assessment Tool to Identify Pain in Patients with Dementia
Running head: BEHAVIORAL ASSESSMENT TOOLS TO IDENTIFY PAIN Effectiveness of a Behavior Assessment Tool to Identify Pain in Patients with Dementia Tai Blake Amy Brown Vanessa Gonzales-Lopez Jessica Hull
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More informationDetecting Suspect Examinees: An Application of Differential Person Functioning Analysis. Russell W. Smith Susan L. Davis-Becker
Detecting Suspect Examinees: An Application of Differential Person Functioning Analysis Russell W. Smith Susan L. Davis-Becker Alpine Testing Solutions Paper presented at the annual conference of the National
More informationRunning head: CPPS REVIEW 1
Running head: CPPS REVIEW 1 Please use the following citation when referencing this work: McGill, R. J. (2013). Test review: Children s Psychological Processing Scale (CPPS). Journal of Psychoeducational
More informationNeuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments
Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments Jason E. Schillerstrom, MD schillerstr@uthscsa.edu Schillerstrom
More informationORIGINAL CONTRIBUTION. Risk Factors for Mild Cognitive Impairment. study the Cardiovascular Health Study Cognition Study.
Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study Part 2 ORIGINAL CONTRIBUTION Oscar L. Lopez, MD; William J. Jagust; Corinne Dulberg, PhD; James T. Becker,
More informationLatent Trait Standardization of the Benzodiazepine Dependence. Self-Report Questionnaire using the Rasch Scaling Model
Chapter 7 Latent Trait Standardization of the Benzodiazepine Dependence Self-Report Questionnaire using the Rasch Scaling Model C.C. Kan 1, A.H.G.S. van der Ven 2, M.H.M. Breteler 3 and F.G. Zitman 1 1
More informationScreening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire
ORIGINAL ARTICLE https://doi.org/10.30773/pi.2017.08.24 Print ISSN 1738-3684 / On-line ISSN 1976-36 OPEN ACCESS Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia
More informationCognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.
Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence
More informationStroke Drivers Screening Assessment European Version 2012
Stroke Drivers Screening Assessment European Version 2012 NB Lincoln, KA Radford, FM Nouri University of Nottingham Introduction The Stroke Drivers Screening Assessment (SDSA) was developed as part of
More informationReadings: Textbook readings: OpenStax - Chapters 1 13 (emphasis on Chapter 12) Online readings: Appendix D, E & F
Readings: Textbook readings: OpenStax - Chapters 1 13 (emphasis on Chapter 12) Online readings: Appendix D, E & F Plous Chapters 17 & 18 Chapter 17: Social Influences Chapter 18: Group Judgments and Decisions
More informationThe neuropsychological profiles of mild Alzheimer s disease and questionable dementia as compared to age-related cognitive decline
Journal of the International Neuropsychological Society (2003), 9, 720 732. Copyright 2003 INS. Published by Cambridge University Press. Printed in the USA. DOI: 10.10170S1355617703950053 The neuropsychological
More informationProcess of a neuropsychological assessment
Test selection Process of a neuropsychological assessment Gather information Review of information provided by referrer and if possible review of medical records Interview with client and his/her relative
More informationAnalysis of Verbal Fluency Ability in Amnestic and Non-Amnestic Mild Cognitive Impairment
Archives of Clinical Neuropsychology 28 (2013) 721 731 Analysis of Verbal Fluency Ability in Amnestic and Non-Amnestic Mild Cognitive Impairment Alyssa Weakley 1, Maureen Schmitter-Edgecombe 1, *, Jonathan
More informationDementia, Cognitive Aging Services and Support
Dementia, Cognitive Aging Services and Support Ronald C. Petersen, Ph.D., M.D. Professor of Neurology Mayo Clinic College of Medicine Rochester, MN NASUAD Washington September 2, 2015 Disclosures Pfizer,
More informationGait abnormalities as early signs of MCI
Demensfondens forskningsstipendier Anna Nordström Gait abnormalities as early signs of MCI With aim To evaluate spatiotemporal gait parameters as predictor of mild cognitive impairment (MCI) in A population
More information